Who is sponsoring NCT06128343?

NCT06128343 is sponsored by University Hospital, Toulouse.

What drugs are being tested in NCT06128343?

Interventions in NCT06128343: collection of biological samples.

What condition does NCT06128343 study?

NCT06128343 studies Adenocarcinoma, Carcinoma, Neoplasms.

Is NCT06128343 still recruiting?

NCT06128343 is currently recruiting now. Last updated 19 March 2026.

Last reviewed 2026-03-19 · How we verify

NCT06128343: BACAP-2

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Anatomical-Clinical Base of Adenocarcinoma Pancreatic

Recruiting now Last updated 19 March 2026

What this trial tests

trial testing collection of biological samples in Adenocarcinoma in 1,500 participants. Currently enrolling.

Timeline

16 November 2023

Primary endpoint
31 January 2035

28 February 2035

Quick facts

Lead sponsor	University Hospital, Toulouse
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	1,500
Start date	16 November 2023
Primary completion	31 January 2035
Estimated completion	28 February 2035
Sites	8 locations across France

Drugs / interventions tested

collection of biological samples — full drug profile →

Conditions studied

Adenocarcinoma — all drugs for Adenocarcinoma →
Carcinoma — all drugs for Carcinoma →
Neoplasms — all drugs for Neoplasms →

Sponsor

University Hospital, Toulouse

Who can join

Adults 18 to 120, any sex, with Adenocarcinoma or Carcinoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

BACAP-2 is a prospective biobank dedicated to the pancreatic adenocarcinoma including clinical data and biological samples from tumor. The aim is to enrich the previous propective collection BACAP in order to support future research projects.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Early detection of pancreatic cancer by liquid biopsy "PANLIPSY": a french nation-wide study project.
Bardol T, Dujon AM, Taly V, Dunyach-Remy C, et al · · 2024 · cited 10× · PMID 38853244 · DOI 10.1186/s12885-024-12463-8

Verify or expand the search:

Other trials of collection of biological samples

Trials testing the same drug.

NCT04355234 — Prevalence and Impact of COVID-19 Infection in Pregnant Women, Fetuses and Newborns · NA · completed

Other recruiting trials for Adenocarcinoma

Currently open trials in the same condition.

NCT06996249 — Prospective Data Collection Initiative on Thoracic Malignancies · recruiting
NCT06649474 — Evaluation, in Humans, of the Correlation Between Hepatotoxicity, Neurotoxicity Induced by Oxaliplatin, and Blood Levels · NA · recruiting
NCT05581121 — PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer · Phase 3 · recruiting
NCT05922930 — Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management · Phase 1, PHASE2 · recruiting
NCT06337760 — YOUNg Adults With Gastro-inteSTinal (GI) and nEuroendocrine canceRs. · recruiting

Other University Hospital, Toulouse trials

Trials by the same sponsor.

NCT07497750 — Impact of Artificial Intelligence Algorithm-driven Versus Standard Lifestyle Intervention in Non-Alcoholic Fatty Liver D · NA · not yet recruiting
NCT07507240 — The Benefits of a Care Pathway Combining Remote Monitoring and Support From a Nurse After a Change in Anti-epileptic Tre · NA · not yet recruiting
NCT07524088 — Contamination of Young Children Hair During Acute Cannabis Intoxication · NA · not yet recruiting
NCT07470580 — Radiofrequency Ablation Versus Adrenalectomy for Adenoma in Patients With Primary Aldosteronism and Hypertension · NA · not yet recruiting
NCT07423988 — Evaluation of Changes in Sleep Efficiency Among PIC DU MIDI Staff Between Nights Spent at Home and Nights Spent in the W · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06128343 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Toulouse
Last refreshed: 19 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06128343.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing